Skip to main content

Advertisement

Log in

Continuous low-level apomorphine administration induces motor abnormalities and hallucinogen-like behaviors

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Continuous low-level (0.825 mg/kg/h for 20 h) administration of AP through SC in-dwelling silicone reservoirs in the rat induced behavioral and biochemical changes that were similar to those induced by low levels (0.1 mg/kg) of acutely administered AP (decreased behavioral activity and decreased dopamine metabolism in the striatum). With longer periods of continuous AP exposure (40 h or more) the activity-depressing effects of low-level AP diminished. Concurrently a novel behavioral syndrome emerged characterized by limb flicks, body shakes, sudden orienting responses, and motor abnormalities, such as tremors of the jaw muscles, chewing movements, prominent tongue extensions, and body ‘tics’. This behavioral syndrome became more apparent following cessation of drug treatment. These novel behavioral changes, which were accompanied by increased behavioral responsiveness to acutely administered AP and amphetamine, were correlated with increased levels of dopamine, homovanillic acid, and 3,4-dihydroxyphenylacetic acid in the striatum but not the nucleus accumbens. This novel behavioral syndrome appears to reflect a rebound increase in dopaminergic mechanisms in striatum following their chronic suppression by low levels of AP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Aghajanian GK, Bunney BS (1975) Dopaminergic and nondopaminergic responses to putative transmitters. In: Boissier JR, Hippius H, Pichot D (eds) Neuropsychopharmacology. Elsevier, Amsterdam, pp 444–452

    Google Scholar 

  • Andén EE, Rubenson A, Fuxe K, Hokfelt T (1967) Evidence for dopamine receptor stimulation by apomorphine. J Pharm Pharmacol 19:627–629

    Google Scholar 

  • Angrist B, Sathanathan G, Gershon S (1973) Behavioral effects of l-dopa in schizophrenic patients. Psychopharmacology 31:1–12

    Google Scholar 

  • Angrist B, Sathanathan G, Wilk S, Gershon S (1974) Amphetamine psychosis: behavioral and biochemical aspects. J Psychiatr Res 11:13

    Google Scholar 

  • Angrist B, Rotogen J, Gershon S (1980) Response to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects. Psychopharmacology 67:31–38

    Google Scholar 

  • Carlsson A (1975) Receptor-mediated control of dopamine metabolism. In: Usdin E, Bunney BS (eds) Pre- and postsynaptic receptors. Dekker, New York, p 49

    Google Scholar 

  • Corsini GU, Del Zompo M, Cinachetti L, Mangoni A, Gessa GL (1977) Sedative, hypnotic, and antipsychotic effects of low doses of apomorphine in man. Adv Biochem Psychopharmacol 16:645–648

    Google Scholar 

  • Creese I, Iversen S (1973) Blockade of amphetamine-induced motor stimulation in the adult rat following neonatal treatment with 6-hydroxydopamine. Brain Res 55:369–382

    Google Scholar 

  • Creese I, Burt DR, Synder S (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antipsychotic drugs. Science 192:481–483

    Google Scholar 

  • Davis JM, Jankowsky DS (1974) Amphetamine and methylphenidate psychosis. In: Usdin E, Synder S (eds) Frontiers in catecholamine research. Pergamon, Oxford, pp 977–987

    Google Scholar 

  • DiChiara G, Porceddu ML, Vargu L, Argiolas A, Gessa G (1976) Evidence for dopamine receptors mediating sedation in the mouse. Nature 244:564

    Google Scholar 

  • Ellinwood EH, Escalante O (1970) Behavioral and histopathological findings during chronic methedrine intoxication. Biol Psychiatry 2:27–35

    Google Scholar 

  • Ellinwood EH, Kilbey MM (1977) Chronic stimulant intoxication models of psychosis. In: Hanin I, Usdin E (eds) Animals models in psychiatry and neurology. Pergamon, Oxford, pp 61–74

    Google Scholar 

  • Ellison G, Morris W (1981) Opposed stages of continuous amphetamine administration. Parallel alterations in motor stereotypes and in vivo spiroperidol. Eur J Pharmacol 74:207–214

    Google Scholar 

  • Ellison G, Ratan R (1982) The late stage following continuous amphetamine administration to rats is correlated with altered dopamine but not serotonin metabolism. Life Sci 31:771–778

    Google Scholar 

  • Ellison G, Eison M, Huberman H (1978) Stages of amphetamine intoxication: Delayed appearance of paranoid-like behaviors in rat colonies. Psychopharmacology 56:293–299

    Google Scholar 

  • Ellison G, Eison M, Huberman H, Daniel F (1979) Long-term changes in copaminergic innervation of caudate nucleus after continuous amphetamine administration. Science 201:276–278

    Google Scholar 

  • Ellison G, Neilson E, Lyon M (1981) Animal models of psychosis: Hallucinatory behaviors in monkeys during the late stage of continuous amphetamine intoxication. J Psychiatr Res 16:13–22

    Google Scholar 

  • Grabowska M (1976) The involvement of serotonin in the mechanism of central action of apomorphine. Pol J Pharmacol 28:389–394

    Google Scholar 

  • Griffith J, Cavanaugh J, Held N, Oates J (1972) d-Amphetamine: Evaluation of psychomotor properties in man. Arch Gen Psychiatry 26:97–100

    Google Scholar 

  • Janowsky DS, El-Yousef MK, Davis JM (1973) Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. Arch Gen Psychiatry 28:185–190

    Google Scholar 

  • Kehr W, Carlsson A, Lindquist M (1975) Biochemical aspects of dopamine agonists. In: Calne D, Chase TN, Barbeau A (eds) Dopamine mechanisms. Raven, New York, pp 185–196

    Google Scholar 

  • Melzacka M, Wiszniowka P, Vetulani J (1978) The distribution of apomorphine in rat brain: Possible behavioral correlates. Pol J Pharmacol 30:335–345

    Google Scholar 

  • Neilson E, Lee T, Ellison G (1980a) Following several days of long-term administration d-amphetamine acquires hallucinogen-like properties. Psychopharmacology 68:197–200

    Google Scholar 

  • Neilson E, Neilson M, Ellison G, Braestrup C (1980b) Decreased spiroperidol binding and LSD binding in rat brain after continuous amphetamine. Eur J Pharmacol 66:149–154

    Google Scholar 

  • Roth RH, Waters J, Aghajanian GK (1973) Effect of impulse flow on the release and synthesis of dopamine in the rat striatum. In: Usdin E, Snyder S (eds) Frontiers in catecholamine research. Pergamon, Oxford, pp 567–574

    Google Scholar 

  • Schwartz JC, Costentin J, Martres MP, Protais P, Baudry M (1978) Modulation of receptor mechanisms in the CNS: Hyperand hyposensitivity to catecholamines. Neuropharmacology 17:665–685

    Google Scholar 

  • Smith RC, Tamminga C, Davis JM (1977a) Effect of apomorphine on schizophrenic symptoms. J Neural Transm 40:171–176

    Google Scholar 

  • Smith RC, Tamminga C, Haraszti J, Paudey J, Davis JM (1977b) Effect of dopamine agonists in tardive dyskinesia. Am J Psychiatry 134:763–768

    Google Scholar 

  • Tamminga CA, Schaffer MH, Smith RC, Davis JM (1978) Schizophrenic symptoms improve with apomorphine. Science 200:567–568

    Google Scholar 

  • Trulson ME, Jacobs BL (1979) Long-term amphetamine treatment decreases brain serotonin metabolism: Implications for theories of schizophrenia. Science 205:1295–1297

    Google Scholar 

  • Walters JR, Bunney BS, Roth RH (1975) Piribedil and apomorphine: Pre- and postsynaptic effects on dopamine synthesis and neuronal activity. Adv Neurol 9:273–284

    Google Scholar 

  • Westerink BHC, Spaan SJ (1982) On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in rat brain. J Neurochem 38:680–686

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davis, R.E., Sant, W.W. & Ellison, G. Continuous low-level apomorphine administration induces motor abnormalities and hallucinogen-like behaviors. Psychopharmacology 85, 1–7 (1985). https://doi.org/10.1007/BF00427314

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00427314

Key words

Navigation